Tim Bodicoat

• For Researchers

Making a startup out of a scientist

Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation. Adendra Therapeutics want to create a new kind of immunotherapy using novel insights into dendritic cell biology. We spoke to co-founder and CEO Raj Mehta about the road to commercialisation.

26 April 2023